Balanced news tone
News Sentiment
4582 sentiment intelligence
SymBio Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
62/100 classification confidence.
directly relevant articles
high-authority source matches
-7.8% over one week, +1.4% over four weeks, trend inactive, and below fair value.
Evo Fund Sells SymBio Pharmaceuticals Shares, Stake Drops to 25.91%
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Evo Fund Sells SymBio Pharmaceuticals Shares, Stake Drops to 25.91%
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 06 Jul 2026 05:35
- Source
- finance.biggo.com
Enterprise value to EBIT forward of Symbio Pharmaceuticals Limited – TSE:4582
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 Jun 2026 17:56
- Source
- TradingView
Symbio Pharmaceuticals Limited Actuals & Estimates (TSE:4582)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 09:00
- Source
- TradingView
Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 11 May 2026 07:00
- Source
- ad-hoc-news.de